Racial Inequities in Hypertension Treatment Intensification

Despite experiencing an increased risk for hypertension, Black patients often constitute a small proportion of clinical trial participants leading to a lack of data supporting evidence-based treatment decisions in this demographic. Until the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial, in which more than a third of participants were black, there was limited [โฆ]